-
-
-
-
-
-
-
AstraZeneca's Tagrisso and Orpathys combo meets Phase III goals
-
-
-
-
-
-
-
AstraZeneca (AZN) call put ratio 1.7 calls to 1 put into share price lower before the bell
-
-
-
-
-
-
-
AstraZeneca drug shows survival benefit in gastric cancer trial
-
-
-
-
-
-
-
BridgeBio Pharma (BBIO) PT Raised to $120 at H.C. Wainwright
-
-
-
-
-
-
-
AstraZeneca's Datroway recommended for EU approval in breast cancer
-
-
-
-
-
-
-
AstraZeneca reports positive SERENA-6 trial results for camizestrant
-
-
-
-
-
-
-
Trump to unveil more discounted prescription drug options - CNBC
-
458,050 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

